Benzbromarone CAS#3562-84-3
CAS Number: 3562-84-3
Chemical Formula: C17H12Br2O3
Synonyms:
LABOTEST-BB LT00134669
BENZBROMARONE
(3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone
MOQ (Minimum Order Quantity): 1 FCL (Full Container Load)
Appearance: White Solid
Benzbromarone CAS#3562-84-3
Benzbromarone,a non-competitive inhibitor of xanthine oxidase,is apotent uricosuric drug used in the treatment of gout.
Benzbromarone is a benzofuran derivative chemically related to amiodarone. It increases uric acid excretion by non-specificallyinhibiting its tubular reabsorption.
lt is used in patients with venous disorders to prevent,retard,or reverse varicose degenerative changes in the vessel wall.
Benzbromarone causes diarrhea (3-4% of patients), urate and oxalate stones,urinary sand,renal colic,and allergy in a small number of patients.Liver damage, which reverses after withdrawal, has been described (SEDA-18,108).
Benzbromarone Chemical Properties |
Melting point | 151° |
Boiling point | 514.1±50.0 °C(Predicted) |
density | 1.6211 (rough estimate) |
refractive index | 1.6010 (estimate) |
storage temp. | Inert atmosphere,2-8°C |
solubility | Practically insoluble in water, freely soluble in acetone and in methylene chloride, sparingly soluble in ethanol (96 per cent). |
pka | 4.66±0.25(Predicted) |
form | Solid |
color | White to Light yellow |
Merck | 14,1065 |
Major Application | forensics and toxicology |
InChI | InChI=1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3 |
InChIKey | WHQCHUCQKNIQEC-UHFFFAOYSA-N |
SMILES | C(C1=CC(Br)=C(O)C(Br)=C1)(C1C2=CC=CC=C2OC=1CC)=O |
CAS DataBase Reference | 3562-84-3(CAS DataBase Reference) |
EPA Substance Registry System | Methanone, (3,5-dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)- (3562-84-3) |
Safety Information |
Hazard Codes | Xn |
Risk Statements | 22 |
Safety Statements | 36 |
RIDADR | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
RTECS | OB1804200 |
TSCA | TSCA listed |
HS Code | 2932.99.7000 |
HazardClass | 6.1(b) |
PackingGroup | III |
Storage Class | 6.1C - Combustible acute toxic Cat.3 |
Hazard Classifications | Acute Tox. 3 Oral |
Toxicity | LD50 oral in rat: 248mg/kg |
Product Application Of Benzbromarone CAS#3562-84-3
Benzbromarone is a benzofuran derivative that has been reported to lower serum urate levels in animals and human studies. In normal and hyperuricaemic subjects, benzbromarone reduced serum uric acid levels by one-third to one-half. In comparison with other urate-lowering drugs, 80 mg of micronized or 100 mg of nonmicronized benzbromarone had equal urate-lowering activity to 1–1.5 g of probenecid or 400–800 mg of sulfinpyrazone.
The mechanism of the urate-lowering activity of benzbromarone appears to be attributable to its uricosuric activity. In rats, benzobromarone inhibited urate reabsorption in the proximal tubules when given at 10 mg/kg i.v. In isolated rat liver preparation, benzbromarone inhibits xanthine oxidase in vitro but not in vivo . In humans, this compound only weakly inhibits xanthine oxidase and no increase in urinary excretion of xanthine or hypoxanthine was observed. After oral administration, about 50% of benzbromarone is absorbed. The drug undergoes extensive dehalogenation in the liver and is excreted mainly in the bile and feces. For control of gout the usual therapeutic dose is 100–200 mg daily. Benzbromarone has few side effects and is usually well tolerated.
Fact Factory and Equipment Show
Fast delivery time
Inventory 2-3 working days New production 7-10 working days


